Navigation Links
Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
Date:5/6/2008

3 or greater).

Nephrotoxicities and ototoxicities were rare and mild.

Poniard anticipates presenting efficacy and safety data at scientific meetings, including preliminary data from the Phase 2 and updated data from the Phase 1 CRC trials at ASCO in June.

About Picoplatin

Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. In addition to the ongoing Phase 2 clinical trial in patients with metastatic CRC, Poniard is evaluating intravenous picoplatin in an ongoing pivotal Phase 3 trial, known as SPEAR (Study of Picoplatin Efficacy After Relapse), in SCLC. This registration trial currently is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration and is evaluating overall survival as the primary endpoint. The Company is also evaluating intravenous picoplatin in an ongoing Phase 2 clinical trial for the treatment of hormone-refractory prostate cancer. Oral picoplatin is being evaluated in a Phase 1 clinical trial in solid tumors. The oral formulation of picoplatin has the same active pharmaceutical ingredient as the intravenous formulation. Picoplatin has not been approved by any regulatory authority for use in humans.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's business objectives and strate
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
2. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
3. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
4. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
5. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
6. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
7. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
9. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... South Africa , May 6, ... kills more people than HIV/AIDS, malaria and tuberculosis combined[1]. Approximately ... percent can be cured with the right treatment[3]. Together with ... are working to build up their radiation therapy infrastructures and ... cancer patients worldwide would benefit from radiation therapy[4] during the ...
(Date:5/6/2015)... May 05, 2015 Research and Markets ... of the "Chromatography (Instruments and Reagents) Global ... their offering. Chromatography is an analytical ... component of a complex mixture by differential movement ... the scientists have considered chromatography as an esoteric ...
(Date:5/6/2015)... DUBLIN , May 06, 2015 Research ... announced the addition of the "Global Insulin ... offering. Highly advanced technology like ultrasound ... of modern insulin patches. Depending upon the type ... be out of reach of several patients. In ...
Breaking Medicine Technology:Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2Global Insulin Patch Market Opportunity Analysis 2015 2
... 2011 Cempra Pharmaceuticals Inc. today announced that Prabhavathi Fernandes, ... upcoming investor conferences in Paris.  Dr. Fernandes will present at ... CET, May 24, at the Hilton Arc de Triomphe.  Dr. ... at 3:00 p.m. CET, May 24, at the Paris Marriott ...
... 2011 Anaphore Inc. today announced that Michael ... joined Anaphore,s senior management team. Dr. ... and development partnership with Mitsubishi Tanabe Pharma Corporation, ... shaping Anaphore,s corporate strategy. Mr. Logan will work ...
Cached Medicine Technology:Cempra Pharmaceuticals to Present at Two Investor Conferences in Paris 2Anaphore Appoints Michael F. Haller, Ph.D., Senior Vice President of Strategic Partnerships and H Casey Logan Senior Vice President of Business Development 2Anaphore Appoints Michael F. Haller, Ph.D., Senior Vice President of Strategic Partnerships and H Casey Logan Senior Vice President of Business Development 3
(Date:5/6/2015)... (PRWEB) May 06, 2015 Imprivata ... announced that CTO David Ting will lead a discussion ... associated data security and user authentication challenges, during ... The session will focus on the benefits of creating ... which care providers and patients can share information. It ...
(Date:5/6/2015)... A quality built chicken coop condo with a wheel ... to raise chickens on a pasture. By installing a wheel ... have a chicken tractor that stands up to being moved around ... it is able to flex to uneven ground without losing its ... are fertilized, and it will help provide the chickens with fresh ...
(Date:5/6/2015)... FL- May 05, 2014 (PRWEB) May 06, 2015 ... Grant Lock accepted, on behalf of MEBC, an ... organizations from JDA Software during FOCUS 2015, JDA’s ... attendees across the manufacturing, retail and wholesale distribution ... ensuring that their clients are receiving services that ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Prime ... supplier, is excited to announce a new series ... reduce the industry’s carbon footprint while improving treatment ... feature Eco-Flex™, the world’s first waste ... a game-changer for hydrotherapists,” claims the company’s president, ...
(Date:5/6/2015)... of Prussia, PA (PRWEB) May 06, 2015 ... Process Outsourcing solutions to the Medicare Advantage, Medicare Part ... finalists in the Continuity and Resilience Team category at ... the Business Continuity Institute to recognize the outstanding contribution ... operating in the North America Region, including the USA ...
Breaking Medicine News(10 mins):Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:TMG Health Recognized by the Business Continuity Institute 2Health News:TMG Health Recognized by the Business Continuity Institute 3
... labels to help cut heart disease, according to researchers from ... their arguments in this week's British Medical Journal, say that ... number one killer, estimated to be responsible for almost 50 ... cardiovascular disease is reported to cost the EU economy an ...
... because a staff nurse has refused to send an ambulance to ... had an agonizing pain in her lower abdomen. Hence she called ... could not have an ambulance and had to wait for another ... the GP arrived he just gave her some painkillers. ...
... 35-year-old woman in Madhya Pradesh survived carrying a dead foetus ... Friday at the government hospital at Khargone, 348 km from ... removed from her womb. ,Renubai conceived two years ... the seventh month of her pregnancy, her family members thought ...
... it has received the tentative new drug approval ... anti-HIV treatment. // ,The fixed drug ... Abacavir 300mg Tablets, the company informed the Bombay ... is cost-effective and reduces the threat of resistance ...
... of a bird flu vaccine against the deadly H5N1 variety ... unvaccinated monkeys, by researchers at two universities.// ,According ... University, the results are expected to be known within about ... shed light on numerous aspects of the strain's infection mechanism ...
... Act, celebrating its third anniversary, has reduced secondhand smoke ... a study conducted by RTI International. ,According to ... of Health’s Tobacco Control Program, exposure to secondhand smoke ... in the year following the implementation of the law. ...
Cached Medicine News:Health News:Scientists Push for Labeling of all Fats to Avoid Heart Disease 2Health News:New York’s Secondhand Smoke Exposure Continues to Declin 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: